Jnana Therapeutics
Kevin Kinsella is the founder of Avalon Ventures. He has specialized in the formation, financing and development of more than 125 early-stage companies, including: Athena Neurosciences Onyx Pharmaceuticals, Inc. [ONXX]; Sequana, Vertex Pharmaceuticals [VRTX], Synaptics [SYNA], Vocera Communications [VCRA], Amira Pharmaceuticals (acquired by BMS), AnaptysBio, JNANA and Eikonizo. Mr. Kinsella was the founding chairman of Athena Neurosciences, Aurora Biosciences, Landmark Graphics, NeoRx, Onyx Pharmaceuticals, Synaptics, Vertex Pharmaceuticals, X-Ceptor and Sequana Therapeutics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Jnana Therapeutics
1 followers
Jnana is building the first drug discovery platform dedicated to SLC transporters. This proprietary chemistry and biology platform allows the company to rapidly and comprehensively address therapeutic targets across the greater the 400-member membrane protein family